Integration of genomic and transcriptomic layers in RNA‐Seq data leads to protein interaction modules with improved Alzheimer's disease associations

Elif Düz,Atılay İlgün,Fatma Betül Bozkurt,Tunahan Çakır

DOI: https://doi.org/10.1111/ejn.16600

IF: 3.698

2024-11-16

European Journal of Neuroscience

Abstract:Workflow of the study. (a) ROSMAP RNA‐Seq data was used to detect DEGs and genes with pathogenic variants, and (b) subnetwork discovery analysis was performed by mapping the identified genes on the human protein interactome. (c) Subnetworks were divided into modules, and functional units of the modules were detected with enrichment analysis, and AD‐related genes were identified. PVG: genes with pathogenic variants. Alzheimer's disease (AD) is the most common neurodegenerative disease, and it is currently untreatable. RNA sequencing (RNA‐Seq) is commonly used in the literature to identify AD‐associated molecular mechanisms by analysing changes in gene expression. RNA‐Seq data can also be used to detect genomic variants, enabling the identification of the genes with a higher load of deleterious variants in patients compared with controls. Here, we analysed AD RNA‐Seq datasets to obtain differentially expressed genes and genes with a higher load of pathogenic variants in AD, and we combined them in a single list. We mapped these genes on a human protein–protein interaction network to discover subnetworks perturbed by AD. Our results show that utilizing gene pathogenicity information from RNA‐Seq data positively contributes to the disclosure of AD‐related mechanisms. Moreover, dividing the discovered subnetworks into highly connected modules reveals a clearer picture of altered molecular pathways that, otherwise, would not be captured. Repeating the whole pipeline with human metabolic network genes led to results confirming the positive contribution of gene pathogenicity information and enabled a more detailed identification of altered metabolic pathways in AD.

neurosciences